Paper657182
Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.
Neugebauer G. Cardiovasc Res, 1978. Cited by 140 papers, by iCite.
Cite this record
ConductScience Library. Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog. Papers, record 657182. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/657182
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular System | Major topic |
| Verapamil | Major topic |
| Animals | |
| Coronary Circulation | |
| Dogs | |
| Hemodynamics | |
| Myocardial Contraction | |
| Vascular Resistance |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37983978 | A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis. | Clin Pharmacol Ther | 2024 | https://conductscience.org/library/papers/37983978 | PubMed |
| 36763530 | The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/36763530 | PubMed |
| 27531061 | Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein. | Biochem Pharmacol | 2016 | https://conductscience.org/library/papers/27531061 | PubMed |
| 26823559 | Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein. | Biosci Rep | 2016 | https://conductscience.org/library/papers/26823559 | PubMed |
| 24532601 | Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs. | J Infect Dis | 2014 | https://conductscience.org/library/papers/24532601 | PubMed |
| 21592185 | Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity. | Br J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21592185 | PubMed |
| 20222974 | Effect of levosimendan in experimental verapamil-induced myocardial depression. | Scand J Trauma Resusc Emerg Med | 2010 | https://conductscience.org/library/papers/20222974 | PubMed |
| 15128524 | Transformation of verapamil by Cunninghamella blakesleeana. | Appl Environ Microbiol | 2004 | https://conductscience.org/library/papers/15128524 | PubMed |
| 9569055 | Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9569055 | PubMed |
| 8398588 | R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate. | Br J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8398588 | PubMed |
| 7710958 | Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7710958 | PubMed |
| 7206587 | Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatment. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/7206587 | PubMed |
| 7128672 | Clinical pharmacokinetics of verapamil in patients with atrial fibrillation. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7128672 | PubMed |
| 6934538 | Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6934538 | PubMed |
| 6404580 | Reliability of antiarrhythmic drug plasma concentration monitoring. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6404580 | PubMed |
| 6362951 | Clinical pharmacokinetics of verapamil. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6362951 | PubMed |
| 6339196 | Calcium antagonists. Pharmacokinetic properties. | Drugs | 1983 | https://conductscience.org/library/papers/6339196 | PubMed |
| 4065190 | Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4065190 | PubMed |
| 4029246 | Pharmacokinetics of verapamil in patients with renal failure. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4029246 | PubMed |
| 3803414 | Pharmacokinetics of verapamil in patients with hypertension. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3803414 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/657182
GET https://conductscience.org/api/papers/v1/657182/cited_by?page=2